sponsored
PatientsVille.com Logo

PatientsVille

Cymbalta and Diclofenac

Compare Side Effects

% of total side effects reported by users. DISCLAIMER: ALL DATA PROVIDED AS-IS. Data Source: openfda.gov.
Side EffectCymbaltaDiclofenac
NAUSEA4.3% 3.1%
DRUG INEFFECTIVE2.7% 3.6%
DIZZINESS3.6% 2.1%
FATIGUE3.3% 2.4%
HEADACHE3.2% 2.4%
DRUG WITHDRAWAL SYNDROME3% 0%
PAIN2.4% 2.9%
INSOMNIA2.8% 0.9%
VOMITING1.9% 2.5%
ANXIETY2.5% 0.9%
ARTHRALGIA1.3% 2.4%
PARAESTHESIA2.4% 0.7%
DIARRHOEA2% 2.2%
DYSPNOEA1.2% 2.1%
DEPRESSION2% 1%
SUICIDAL IDEATION1.9% 0%
MALAISE1.4% 1.8%
PAIN IN EXTREMITY1% 1.8%
FEELING ABNORMAL1.8% 0.8%
HYPERHIDROSIS1.8% 0.6%
DRUG INTERACTION0.6% 1.7%
IRRITABILITY1.6% 0%
FALL1.5% 1.5%
OFF LABEL USE1.5% 0.9%
CONFUSIONAL STATE1.5% 0.8%
PYREXIA0.6% 1.5%
AGITATION1.5% 0%
ASTHENIA1.2% 1.4%
BACK PAIN1% 1.4%
WEIGHT DECREASED0.9% 1.4%
RASH0.7% 1.4%
TREMOR1.4% 0.6%
ABDOMINAL PAIN0.6% 1.4%
DRUG HYPERSENSITIVITY0.6% 1.3%
VERTIGO1.3% 0%
SOMNOLENCE1.2% 0.9%
PRURITUS0.7% 1.2%
CONDITION AGGRAVATED0.6% 1.2%
PNEUMONIA0.6% 1.2%
ANAEMIA0% 1.2%
RHEUMATOID ARTHRITIS0% 1.2%
WEIGHT INCREASED1.1% 0.7%
DECREASED APPETITE0.7% 1.1%
ABDOMINAL PAIN UPPER0.6% 1.1%
ACUTE KIDNEY INJURY0% 1.1%
GAIT DISTURBANCE0.8% 1%
CHEST PAIN0.6% 1%
AFFECT LABILITY1% 0%
RENAL FAILURE ACUTE0% 1%
HYPERTENSION0.7% 0.9%
COUGH0.5% 0.9%
ABDOMINAL DISCOMFORT0.4% 0.9%
HYPOTENSION0.4% 0.9%
GASTROINTESTINAL HAEMORRHAGE0% 0.9%
RENAL FAILURE0% 0.9%
DYSPHORIA0.9% 0%
CONSTIPATION0.8% 0.8%
MUSCLE SPASMS0.7% 0.8%
OEDEMA PERIPHERAL0.5% 0.8%
MEMORY IMPAIRMENT0.8% 0.5%
HYPERSENSITIVITY0.4% 0.8%
NIGHTMARE0.8% 0%
HAEMOGLOBIN DECREASED0% 0.8%
URTICARIA0% 0.8%
ERYTHEMA0% 0.8%
LETHARGY0.8% 0%
BLOOD PRESSURE INCREASED0.7% 0.7%
HYPOAESTHESIA0.7% 0.7%
LOSS OF CONSCIOUSNESS0.6% 0.7%
URINARY TRACT INFECTION0.5% 0.7%
MYALGIA0.5% 0.7%
DRUG DOSE OMISSION0.7% 0.5%
DEATH0.4% 0.7%
DEHYDRATION0.4% 0.7%
JOINT SWELLING0% 0.7%
SLEEP DISORDER0.7% 0%
TOXICITY TO VARIOUS AGENTS0% 0.7%
NASOPHARYNGITIS0% 0.7%
TINNITUS0.7% 0%
CRYING0.7% 0%
SENSORY DISTURBANCE0.7% 0%
ALOPECIA0.5% 0.6%
SUICIDE ATTEMPT0.6% 0.5%
VISION BLURRED0.6% 0.5%
INJECTION SITE PAIN0.4% 0.6%
MUSCULAR WEAKNESS0.4% 0.6%
ANGIOEDEMA0% 0.6%
RENAL IMPAIRMENT0% 0.6%
BLOOD CREATININE INCREASED0% 0.6%
GENERAL PHYSICAL HEALTH DETERIORATION0% 0.6%
ANAPHYLACTIC REACTION0% 0.6%
MYOCARDIAL INFARCTION0% 0.6%
MELAENA0% 0.6%
ARTHRITIS0% 0.6%
SEPSIS0% 0.6%
INTENTIONAL PRODUCT MISUSE0.6% 0%
MUSCULOSKELETAL STIFFNESS0% 0.6%
OSTEOARTHRITIS0% 0.6%
GASTRIC ULCER0% 0.6%
PERIPHERAL SWELLING0% 0.6%
SWELLING0% 0.6%
MOOD SWINGS0.6% 0%
OVERDOSE0% 0.6%
DRY MOUTH0.6% 0%
MIGRAINE0.6% 0%
SINUSITIS0.4% 0.5%
CHILLS0.4% 0.5%
ALANINE AMINOTRANSFERASE INCREASED0.4% 0.5%
SYNCOPE0.4% 0.5%
GASTROINTESTINAL DISORDER0% 0.5%
CHRONIC KIDNEY DISEASE0% 0.5%
FOETAL EXPOSURE DURING PREGNANCY0% 0.5%
MUSCULOSKELETAL PAIN0% 0.5%
BRONCHITIS0% 0.5%
ARTHROPATHY0% 0.5%
INFECTION0% 0.5%
DEPRESSED MOOD0.5% 0%
DISTURBANCE IN ATTENTION0.5% 0%
WITHDRAWAL SYNDROME0.5% 0%
PALPITATIONS0.5% 0%
BALANCE DISORDER0.5% 0%
NEUROPATHY PERIPHERAL0.4% 0%
ANGER0.4% 0%
INFLUENZA LIKE ILLNESS0.4% 0%
AMNESIA0.4% 0%
SEIZURE0.4% 0%
PANIC ATTACK0.4% 0%
HEPATIC ENZYME INCREASED0.4% 0%
BLOOD GLUCOSE INCREASED0.4% 0%
HALLUCINATION0.4% 0%
FIBROMYALGIA0.4% 0%
HEART RATE INCREASED0.4% 0%
NERVOUSNESS0.4% 0%
CONTUSION0.4% 0%
HYPERKALAEMIA0% 0.4%

New treatments are found every day. View current Cymbalta research studies and Diclofenac clinical trials

1